Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial

被引：0

作者：

Parikh, P. J. ^{[1
]}

Lee, P. ^{[2
]}

Low, D. ^{[3
]}

Kim, J. ^{[1
]}

Mittauer, K. E. ^{[4
]}

Bassetti, M. F. ^{[5
]}

Glide-Hurst, C. ^{[5
]}

Raldow, A. ^{[6
]}

Yang, Y. ^{[6
]}

Portelance, L. ^{[7
]}

Zaki, B. ^{[8
]}

Kim, H. ^{[9
]}

Mancias, J. D. ^{[10
]}

Ng, J. ^{[11
]}

Pfeffer, R. M. ^{[12
]}

Mueller, A. ^{[13
]}

Kelly, P. ^{[14
]}

Boldrini, L. ^{[15
]}

Fuss, M., Jr. ^{[16
]}

Chuong, M. D. ^{[17
]}

机构：

[1] Henry Ford Canc Inst, Dept Radiat Oncol, Detroit, MI USA

[2] City Hope Natl Med Ctr, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA

[4] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA

[5] Univ Wisconsin, Carbone Canc Ctr, Dept Human Oncol, Madison, WI USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA

[7] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA

[8] Dartmouth Hitchcock Med Ctr, Hanover, NH USA

[9] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA

[10] Harvard Med Sch, Dept Radiat Oncol, Dana Farber Canc Inst, Dept Radiat Oncol,Brigham & Womens Hosp, Boston, MA 02115 USA

[11] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA

[12] Assuta Med Ctr, Tel Aviv, Israel

[13] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA

[14] Orlando Hlth Canc Inst, Dept Radiat Oncol, Orlando, FL USA

[15] Fdn Policlin Univ A Gemelli IRCCS, Dept Radiol Radiat Oncol & Hematol, Rome, Italy

[16] ViewRay Inc, Mountain View, CA USA

[17] Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA 09

引用

页码：1062 / 1063

页数：2

共 50 条

[21] Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable pancreatic Cancer: Updated Outcomes and Toxicity in Over 100 Patients
Mellon, E. A.
Hoffe, S. E.
Freilich, J. M.
Springett, G. M.
Chuong, M. D.
Hodul, P. J.
Malafa, M. P.
Meredith, K. L.
Park, C. K.
Shridhar, R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S359 - S360
[22] Technical Results for the First Multi-Institutional Sterotactic MR-Guided Adaptive Radiation Therapy (SMART) Trial in Pancreas Cancer
Kim, J.
Parikh, P.
Lee, P.
Chuong, M.
Fuss, M.
Low, D.
MEDICAL PHYSICS, 2022, 49 (06) : E571 - E572
[23] Prospective phase I study of nab-paclitaxel plus gemcitabine with concurrent MR-guided IMRT in patients with locally advanced or borderline resectable pancreatic cancer.
Olsen, Jeffrey R.
Parikh, Parag J.
DeWees, Todd A.
Olsen, Lindsey
Hawkins, William G.
Strasberg, Steven M.
Lim, Kian-Huat
Singh, Preet Paul
Suresh, Rama
Tan, Benjamin R.
Ratner, Lee
Fields, Ryan C.
Amin, Manik A.
Wang-Gillam, Andrea
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[24] Chemotherapy-based split stereotactic body radiation therapy for borderline resectable and locally advanced pancreatic cancer: study protocol of a prospective, single-arm phase II trial
Zheng, Rong
Wang, Congfei
Huang, Xiaoxue
Lin, Qingliang
Huang, Daxin
Li, Xiao-Bo
Huang, Heguang
Xu, Benhua
BMJ OPEN, 2020, 10 (11):
[25] Phase I Trial of Concurrent Stereotactic Body Radiation Therapy and Nelfinavir for Locally Advanced Borderline or Unresectable Pancreatic Cancer-Final Results
Lin, C.
Verma, V.
Ly, Q.
Schwarz, J.
Meza, J.
Sasson, A.
Are, C.
Kos, B.
Grem, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S135 - S135
[26] A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
Saif, Areeba
Verbus, Emily
Erickson, Beth
Kamgar, Mandana
Tsai, Susan
Evans, Douglas
Hernandez, Jonathan M.
Hall, William A.
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 688 - 690
[27] A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
Areeba Saif
Emily Verbus
Beth Erickson
Mandana Kamgar
Susan Tsai
Douglas Evans
Jonathan M. Hernandez
William A. Hall
Annals of Surgical Oncology, 2023, 30 : 688 - 690
[28] Pancreatic Stereotactic Body Radiation Therapy (SBRT) in the Era of Multi-Agent Chemotherapy for Locally Advanced and Borderline Resectable Pancreatic Cancer: A Prospective Single Institution Study
Ellsworth, Susannah
House, Michael
O'Neil, Bert
Shahda, Safi
Nakeeb, Attila
Miller, Amy
Brennan, Sarah
Sehdev, Amikar
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : E8 - E8
[29] Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
Chin, Re-, I
Schiff, Joshua P.
Bommireddy, Anirudh
Kang, Kylie H.
Andruska, Neal
Price, Alexander T.
Green, Olga L.
Huang, Yi
Korenblat, Kevin
Parikh, Parag J.
Olsen, Jefferey
Samson, Pamela P.
Henke, Lauren E.
Kim, Hyun
Badiyan, Shahed N.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 41
[30] Multi-center phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC)
Posner, M.
Chang, K. J.
Rosemurgy, A.
Stephenson, J.
Khan, M.
Reid, T.
Fisher, W. E.
Waxman, I.
Von Hoff, D.
Hecht, R., Jr.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

← 1 2 3 4 5 →